Pharma's 2019 Prognosis Hinges on These Key Themes

Bookmark
(Bloomberg Opinion) -- For the biopharma industry, 2018 was a year marked by generally robust profits and a handful of superlatives. These include Takeda Pharmaceutical Co.’s $62 billion bid for Sh...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.